Tel: +91 124 2821030
Email: info@windlasbiotech.com
Home
About
Our Heritage
EXPERTISE
Our Mission & Vision
Services
Products
Our Brands
Investor Relations
Financial Information
Annual Financials
Quarterly Results
Investor Presentation
Quarterly Results Press Release
Earnings Call Transcript
Audio Transcript
Earnings Conference Call Transcript
Annual Report
Buy Back of Shares
Public Announcement
Daily Reporting
Extinguishment of Shares
Corporate Governance
Committee Composition
List of Directors
Independent Directors
Management Team Information
Code of Conduct
Policies
Annual Return
Credit Rating
Investor Information
Company Fact Sheet
Share Holding Pattern
Stock Prices
Unclaimed dividend
Corporate Announcement
Notice of Board Meeting
Stock Exchange Communication
Monitoring Agency
Statement of Deviation
Secretarial Compliance Report
Schedule of Analyst
Published in Newspaper
Investor Contact
Compliance Officer
Investor Relations
Registrar
Grievance Officer
Contact For Material Event
CSR
Career
Contact
X
Contact us
Schedule of Analyst
Schedule of Analyst
Meeting Intimations
2024-2025
2023-2024
2022-2023
2021-2022
April 26, 2024
April 16, 2024
March 11, 2024
February 26, 2024
February 15, 2024
February 14, 2024
February 9, 2024
January 15, 2024
January 08, 2024
December 13, 2023
November 24, 2023.
November 9, 2023
October 27, 2023
October 16, 2023
October 11, 2023
April, 6 2022
June 20, 2022.
April 24, 2023
March 30, 2023
Marh 9, 2023
December 21, 2022
December 20, 2022
December 5, 2022
November 30, 2022
September 22, 2022
September 13, 2022
September 8, 2022
September 1, 2022
July 20, 2022
July 18, 2022
July 14, 2022
June 29, 2022
March 31, 2022
March 30, 2022
June 29, 2022
February 17, 2022
January 11, 2022
December 10, 2021
Earning Call
Transcript
FY 2023-2024
FY 2022-2023
FY 2021-2022
Earnings Call Transcript Q3 FY24
Earnings Call Transcript Q2 FY24.
Q3
Q2
Q1
Q4
Q3
Q2
Q1
Audio Transcription
Investor
Presentation
FY 23-24
FY 22-23
FY 21-22
Investor Presentation Q3 FY24
Investor Presentation Q2 FY24
Intimation pursuant to Regulation 30 of the SEBl (LODR) Regulation,
Reconciliation of Share Capital Q2 FY 24.
As Certificate under Regulation 74 (5) for Q2 FY 24.
Closure of Trading Window September 30, 2023
Con call for Financial Performance – January 29,2022.
Invite for Investor Meeting September 9, 2021.
Closure of Trading Window September 30, 2021.
Certificate under Reg 74(5)
Reg 74(5) announcement 10 April 2023
Outcome of 22nd AGM held as on September 12, 2023.
Annual Report for FY 2022-23.
22nd AGM Notice
Intimation of Book Closure August 16, 2023
Intimation of Investor Call on Unaudited Financial Results for Q1 FY 24, August 09, 2023”.
Board Meeting Intimation – August 8, 2023
Intimation of Schedule of Analyst & Institutional Investor meeting- July 12, 2023
Intimation of Schedule of Analyst & Institutional Investor meeting- July 11, 2023
Intimation of Schedule of Analyst & Institutional Investor meeting- July 7, 2023
Closure of Trading Window June 30, 2023
June 17th 2023- Clarification to stock Exchange for significant increase in volume in shares of company
Board Meeting Intimation April 28, 2023
Large Entity Disclosure 24 Apr 2023
Reg 7(3) 11032023 11 Apr 2023
Trading Window Closure 31 March 2023
CEO Press Release
Outcome of the Board Meeting February 08, 2023
Schedule of Conference Call to discuss financial performance for quarter ended December 31, 2022
Certificate under Regulation 74(5)- January 12, 2023.
Trading Window Closure 30-12-2022.
November 09,2022 Corrigendum to the Outcome of Board Meeting
Buyback Public Announcement
Closure of Trading Window 30th September 2022.
Intimation of schedule of analyst & Institutional Investor Meeting- 22nd September 2022.
21st AGM Voting results.
21st AGM Proceedings.
Intimation of schedule of analyst & Institutional Investor Meeting- 8th September 2022.
INVESTOR MEETING -1st September 2022
Regulation 34 Annual report FY 21-22 intimation.
Newspaper advertisement of 21st AGM
Book Closure
Q1 FY22-23 Earning Call
Financial Results Q1 FY 22-23
Schedule of Conference Call to discuss financial performance for quarter ended June 30, 2022.
Virtual Meeting - Exchange Intimation
Trading Window Closure Q1
Investor Conference
Press Release
Annual Secretarial Compliance Report for the year ended March 31, 2022
Board Meeting Outcome 12052022
Press Release GMP
Initial Disclosure
Earnings Call
Investor meeting 30th March 2022
Investor meeting 31st March 2022
Investor meeting 17 Feb 2022
Intimation of Schedule of Analyst / Institutional Investor meetings
Investor meeting with the exchanges.
Reg 74(5) certificate
Closure of trading window
Investec conference
Closure of trading window
